Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors
Crossref DOI link: https://doi.org/10.1186/s12943-017-0672-1
Published Online: 2017-06-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mäkinen, Netta
Kämpjärvi, Kati
Frizzell, Norma
Bützow, Ralf
Vahteristo, Pia
Funding for this research was provided by:
Terveyden Tutkimuksen Toimikunta (295693, 260370, 292769)
Sigrid Juséliuksen Säätiö
Syöpäjärjestöt
